Inhibition of Hippo Signaling Through Ablation of Lats1 and Lats2 Protects Against Cognitive Decline in 5xFAD Mice via Increasing Neuronal Resilience Against Ferroptosis
Aging Cell · 2025
DOI: 10.1111/acel.70218 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2025. Verfasst von Robert C Evans und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Systems & Anatomy, University of Texas Health San Antonio, San Antonio, Texas, USA. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, Neurons, Cognitive Dysfunction, Tumor Suppressor Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIH HHS, BLRD VA.
Abstract (Originalsprache)
The Hippo signaling pathway is a key regulator of cell growth and cell survival, and hyperactivation of the Hippo pathway has been implicated in neurodegenerative diseases such as Huntington's disease. However, the role of Hippo signaling in Alzheimer's disease (AD) remains unclear. We observed that hyperactivation of Hippo signaling occurred in the AD model 5xFAD mice. To determine how inhibition of Hippo signaling might affect disease pathogenesis, we generated 5xFAD mice with conditional neuronal ablation of Lats1 and Lats2, the gatekeepers of Hippo signaling activity. Our results indicated that 5xFAD mice with ablation of Lats1 and Lats2 were protected against cognitive decline compared with control 5xFAD mice, and this protection was correlated with a marked reduction in neurodegeneration. Interestingly, primary culture neurons with ablation of Lats1 and Lats2 had significantly increased survival following treatment with chemical inducers of ferroptosis and exhibited reduced lipid peroxidation, the driving force of ferroptotic cell death. Moreover, 5xFAD mice with ablation of Lats1 and Lats2 showed reduced lipid peroxidation, and transcriptomic analysis revealed that 5xFAD mice with ablation of Lats1 and Lats2 had enriched metabolic pathways associated with ferroptosis. These results indicate that inhibition of Hippo signaling activity confers neural protection in 5xFAD mice by augmenting resilience against ferroptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Systems & Anatomy, University of Texas Health San Antonio, San Antonio, Texas, USA.
- Department of Pharmacology, University of Texas Health San Antonio, San Antonio, Texas, USA.
- Research Service, South Texas Veterans Health Care System, San Antonio, Texas, USA.
- Greehey Children's Cancer Research Center, University of Texas Health San Antonio, San Antonio, Texas, USA.
- The Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health San Antonio, San Antonio, Texas, USA.
ORCID-Profile: Qitao Ran
Förderung
- NIA NIH HHS
- NIH HHS
- BLRD VA
- NCI NIH HHS
- National Institute on Aging
- U.S. Department of Veterans Affairs
Zitieren
APA
Evans, R. C., Dar, N. J., Chen, L., Na, R., O'Connor, J. C., Jiang, J., Zheng, S., & Ran, Q. (2025). Inhibition of Hippo Signaling Through Ablation of Lats1 and Lats2 Protects Against Cognitive Decline in 5xFAD Mice via Increasing Neuronal Resilience Against Ferroptosis. Aging Cell. https://doi.org/10.1111/acel.70218
Vancouver
Evans RC, Dar NJ, Chen L, Na R, O'Connor JC, Jiang J, et al. Inhibition of Hippo Signaling Through Ablation of Lats1 and Lats2 Protects Against Cognitive Decline in 5xFAD Mice via Increasing Neuronal Resilience Against Ferroptosis. Aging Cell. 2025. doi:10.1111/acel.70218
BibTeX
@article{Evans2025,
author = {Evans, Robert C and Dar, Nawab John and Chen, Liuji and Na, Ren and O'Connor, Jason C and Jiang, Jing and Zheng, Siyuan and Ran, Qitao},
title = {Inhibition of Hippo Signaling Through Ablation of Lats1 and Lats2 Protects Against Cognitive Decline in 5xFAD Mice via Increasing Neuronal Resilience Against Ferroptosis},
journal = {Aging Cell},
year = {2025},
doi = {10.1111/acel.70218}
}
EUVIMED